Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124951372 | 12495137 | 2 | F | 2016 | 20160704 | 20160624 | 20160714 | EXP | PHFR2016GB004996 | NOVARTIS | 42.00 | YR | F | Y | 0.00000 | 20160714 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124951372 | 12495137 | 1 | PS | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK | U | U | 20007 | ||||||||
| 124951372 | 12495137 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2 MG, QD (3 DAYS) | U | 0 | 2 | MG | QD | ||||||
| 124951372 | 12495137 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | 6 MG, UNK(24 HOURS AFTER CHEMOTHERAPY) | U | 0 | 6 | MG | |||||||
| 124951372 | 12495137 | 4 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 24 HOURS AFTER CHEMOTHERAPY | U | 0 | 6 | MG | |||||||
| 124951372 | 12495137 | 5 | SS | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, QD (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) | U | 0 | 80 | MG | QD | ||||||
| 124951372 | 12495137 | 6 | SS | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) | U | 0 | 80 | MG | QD | ||||||
| 124951372 | 12495137 | 7 | SS | FLOUROURACIL | FLUOROURACIL | 1 | Unknown | UNK (EVERY 3 WEEKS (CYCLICAL)) | U | 0 | |||||||||
| 124951372 | 12495137 | 8 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | UNK (3 CYCLES) | U | 0 | |||||||||
| 124951372 | 12495137 | 9 | SS | DOCETAXEL. | DOCETAXEL | 1 | 3 CYCLES | U | 0 | ||||||||||
| 124951372 | 12495137 | 10 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | Unknown | U | 0 | ||||||||||
| 124951372 | 12495137 | 11 | SS | METOCHLOPRAMIDE | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124951372 | 12495137 | 1 | Product used for unknown indication |
| 124951372 | 12495137 | 2 | Product used for unknown indication |
| 124951372 | 12495137 | 3 | Product used for unknown indication |
| 124951372 | 12495137 | 5 | Product used for unknown indication |
| 124951372 | 12495137 | 7 | Product used for unknown indication |
| 124951372 | 12495137 | 8 | Product used for unknown indication |
| 124951372 | 12495137 | 10 | Product used for unknown indication |
| 124951372 | 12495137 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124951372 | 12495137 | HO |
| 124951372 | 12495137 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124951372 | 12495137 | Arthralgia | |
| 124951372 | 12495137 | Constipation | |
| 124951372 | 12495137 | Decreased appetite | |
| 124951372 | 12495137 | Deep vein thrombosis | |
| 124951372 | 12495137 | Fatigue | |
| 124951372 | 12495137 | Oral pain | |
| 124951372 | 12495137 | Pain | |
| 124951372 | 12495137 | Pain in extremity | |
| 124951372 | 12495137 | Peripheral swelling | |
| 124951372 | 12495137 | Vascular pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |